Extract Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe late
complication of acute pulmonary embolism (PE)[1, 2]. The earlier CTEPH is diagnosed, the …

Although cardiovascular diseases (CVDs) are the leading cause of death worldwide, their
pharmacotherapy remains suboptimal. Thus, there is a clear unmet need to develop more …

Acute heart failure (AHF) represents a broad spectrum of disease states, resulting from the
interaction between an acute precipitant and a patient's underlying cardiac substrate and …

The 2022 European Society of Cardiology (ESC) guidelines [1] are a comprehensive
document, prepared jointly by experts in cardiology and oncology. In the case of oncology …

Patients with chronic lung diseases, particularly interstitial lung disease and chronic
obstructive pulmonary disease, frequently develop pulmonary hypertension, which results in …

Hypoxic pulmonary hypertension (HPH) is characterized by pulmonary vascular sustained
constriction and progressive remodeling, which are initiated by hypoxia then with hypoxia …

Right‐sided heart failure and tricuspid regurgitation are common and strongly associated
with poor quality of life and an increased risk of heart failure hospitalizations and death …

Pulmonary arterial hypertension (PAH) is a severe but treatable form of pre-capillary
pulmonary hypertension caused by pulmonary vascular remodelling. As a result of basic …

Pulmonary hypertension worsens outcome in left heart disease. Stiffening of the pulmonary
artery may drive this pathology by increasing right ventricular dysfunction and lung vascular …

Pulmonary hypertension (PH) is a disease of pulmonary artery stenosis and blockage
caused by abnormal pulmonary artery smooth muscle cells (PASMCs), with high morbidity …